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AbstrACt
Introduction Nudge-interventions aimed at health 
professionals are proposed to reduce the overuse and 
underuse of health services. However, little is known 
about their effectiveness at changing health professionals’ 
behaviours in relation to overuse or underuse of tests or 
treatments.
Objective The aim of this study is to systematically 
identify and synthesise the studies that have assessed the 
effect of nudge-interventions aimed at health professionals 
on the overuse or underuse of health services.
Methods and analysis We will perform a systematic 
review. All study designs that include a control comparison 
will be included. Any qualified health professional, across 
any specialty or setting, will be included. Only nudge-
interventions aimed at altering the behaviour of health 
professionals will be included. We will examine the effect 
of choice architecture nudges (default options, active 
choice, framing effects, order effects) and social nudges 
(accountable justification and pre-commitment or publicly 
declared pledge/contract). Studies with outcomes relevant 
to overuse or underuse of health services will be included. 
Relevant studies will be identified by a computer-aided 
search of the Cochrane Central Register of Controlled Trials 
(CENTRAL) (The Cochrane Library), MEDLINE, CINAHL, 
Embase and PsycINFO databases. Two independent 
reviewers will screen studies for eligibility, extract data 
and perform the risk of bias assessment using the criteria 
recommended by the Cochrane Effective Practice and 
Organisation of Care (EPOC) group. We will report our 
results in a structured synthesis format, as recommended 
by the Cochrane EPOC group.
Ethics and dissemination No ethical approval is required 
for this study. Results will be presented at relevant 
scientific conferences and in peer-reviewed literature.
IntrOduCtIOn
Health professionals’ underuse and overuse 
of health services (eg, medications, screening 
tests, diagnostic tests and treatments) are 
major problems worldwide.1 2 The ways in 
which health professionals make choices 
influence this overuse and underuse, and 
ultimately the value and outcomes of patient 
care.1 3 
There are many examples of the overuse 
of inappropriate care.4 5 This involves health 
professional provision of medical services that 
are discouraged by clinical guidelines because 
they are likely to cause more harm than good, 
or provide little to no clinical benefit. For 
example, a study in China found that 57% of 
patients received antibiotics inappropriately6; 
rates of inappropriate total knee replacement 
were 26% in Spain and 34% in the USA7; the 
Lancet low back pain (LBP) series8–10 displayed 
the worldwide overuse of surgery, opioids and 
imaging for LBP; and arthroscopic surgery for 
degenerative knee disease, a procedure known 
to be ineffective, is performed more than 
2 million times a year across the world.11 12 A 
slightly different example is the prescribing of 
expensive brand name medications that have 
existing generic equivalents. For example, a 
study in the USA found that in 2009, Medicaid 
spent an unnecessary $329 million that could 
have been saved by using generic instead 
of brand name medications.13 Overuse of 
screening tests for cancer has also been docu-
mented.14 Examples include inappropriate 
screening for cervical cancer,15 mammography 
screening for breast cancer16 17 and thyroid 
cancer screening.18–20
strengths and limitations of this study
 ► This will be the first review to explicitly examine the 
effect of nudge-interventions aimed at health pro-
fessionals on the overuse and underuse of health 
services.
 ► This review has a comprehensive search strategy, 
will include many study designs, all health disci-
plines and outcomes related to overuse or underuse 
of any test or treatment.
 ► Nudge-interventions lack definitional and concep-
tual clarity and make the inclusion and exclusion 
criteria difficult to define.
 ► Only English language studies will be included.
 ► The results may be able to inform future strategies 
to address health service overuse and underuse.
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There are also several examples of the underuse of 
appropriate care that is known to improve health.3 For 
example, the CareTrack study21 in Australia found that 
only 57% of patients received appropriate care across 
35 573 healthcare encounters. A 2003 US study22 found 
that only 55% of patients in the USA received recom-
mended care. High quality studies have displayed the 
underuse of anticoagulation in patients with atrial fibril-
lation who are at high risk of stroke23–25 and the underuse 
of beta blockers for patients who have had a myocar-
dial infarction.26 27 There is also underuse of effective 
non-pharmacological treatments, including advice for 
acute LBP28 29 and exercise prescription for a range of 
chronic conditions including heart failure, osteoarthritis 
and chronic fatigue.30–33 Both underuse and overuse can 
drive physical, psychological and social harms for patients, 
and the wasteful misallocation of resources.1 2
Numerous drivers of overuse and underuse of health 
services have been documented.1–4 Thinking strategies at 
the level of the health professional have been proposed 
as one driver of these problems.2 Psychological research 
has identified strategies of cognition34 35 that influence 
health professional judgements in situations of uncer-
tainty and exert a powerful influence on decision-making 
in healthcare.2 36 It is suggested that health professionals 
exhibit ‘predictable’ bounded rationality.37–40 That 
is, when making decisions, rather than being rational 
economic optimisers, they follow mind lines (inter-
nalised tacit guidelines on how to manage common 
problems)41 and heuristics35 39 42–44 (‘common sense’, 
educated guesses, mental rules of thumb or short cuts). 
Because rapid, high-volume clinical decision-making 
is part of the everyday routine of health professionals 
and requires combining and synthesising diverse data 
and performing complex trade-offs between benefits 
and risks, these mostly unconscious heuristics can be 
adaptive and accurate.2 39 45 However, this intuitive deci-
sion-making can also be dysfunctional and lead to skewed 
judgement.37 38 For example, health professionals under-
estimate the harms and overestimate the benefits of many 
tests and treatments.46 Nineteen different types of heuris-
tics and cognitive biases in clinical decision-making have 
been discussed.35 Types frequently mentioned in health 
service improvement conversations44 47–50 include default 
bias or status quo bias (a preference for the current state 
of affairs), framing effects (influenced by the expression 
of the same information in different ways), loss aversion 
(care much more about avoiding losses than care about 
making gains), order effects (influenced by the different 
order of the same information), norms (tendency to 
uphold one’s reputations based on peer or social norms) 
and the salience effect (influenced by the distinctiveness 
of important material).
Researchers have started to focus on ways of harnessing 
these cognitive biases and heuristics to influence health 
professional judgements, choices and behaviours. 
This has led to increasing interest in the field of social 
psychology and behavioural economics. The concept 
of nudge,51–53 in particular, has been proposed as one 
method of promoting ‘right healthcare’.47 54–57 Nudge was 
popularised in 2008 following the publication of the book 
Nudge: Improving Decisions about Health, Wealth, and Happi-
ness by Thaler and Sunstein.51 They defined a nudge as 
'any aspect of the choice architecture that alters people's 
behaviour in a predictable way without forbidding any 
options or significantly changing their economic incen-
tives’. In this way, choice architecture refers to the context 
in which people choose and make decisions. The defini-
tion of nudge has since been updated to provide further 
clarity for researchers and policy-makers.53 The updated 
definition is:
'A nudge is a function of any attempt at influencing 
people’s judgement, choice or behaviour in a predictable 
way that is
1. Made possible because of cognitive boundaries, bi-
ases, routines and habits in individual and social de-
cision-making posing barriers for people to perform 
rationally in their own self-declared interests, and
2. Which works by making use of those boundaries, biases, 
routines and habits as integral parts of such attempts.
The nudge works independently of
a. Forbidding or adding any rationally relevant choice 
options,
b. Changing incentives, in terms of time, trouble, social 
sanctions, economic and so forth, or
c. The provision of factual information and rational 
argumentation.'53
Nudge-interventions are classed as light-touch behav-
iour change strategies.58 It is proposed that nudge, 
through making subtle, but purposeful, changes in how 
choices and information are presented and framed (the 
choice architecture)58 59 in the clinician environment, 
may tap into clinician automatic cognitive processes 
(heuristics) in a beneficial way and push clinicians away 
from both underuse and overuse of health services.57 60 
Nudges can be designed to remind, guide or motivate 
behaviour.57 Nudges should be inexpensive and easy to 
implement, not involve a restriction, be implemented in 
the environment where the target behaviour is performed 
and require minimal conscious processing.51 58 59 Nudge 
is embedded in libertarian paternalism, a political philos-
ophy in which people’s choices are actively guided in 
their best interests but they remain at liberty to behave 
differently.61 It has been suggested that nudges are often 
preferred over more assertive methods (eg, prohibiting 
the prescription of certain medications) as they do not 
force people to behave in a specific manner.62
Some suggest that using nudges in the healthcare system 
may lead to reduced overuse and underuse of health 
services54; and health professionals’ immediate environ-
ment and choice architecture should be purposefully 
designed in a way that directs them towards the provision 
of appropriate care. Other researchers63 64 have expressed 
concern over the potential repercussions of the hastily 
implementation of nudge-interventions. For example, 
there is a concern that nudging may drive unintended, 
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as well as intended, behaviour changes.63 64 We do not 
know if there is evidence that nudge-interventions are 
effective at changing health professionals’ behaviours in 
relation to overuse or underuse of tests or treatments, or 
if results vary depending on the type of nudge, type of 
health professional or the target behaviour. Therefore, 
the objective of this review was  to systematically identify 
and synthesise the studies that have assessed the effect of 
nudge-interventions aimed at health professionals on the 
overuse or underuse of health services.
MEthOds
search strategy
This review protocol has been registered on the PROS-
PERO database (CRD42019123261).
All relevant English studies meeting the inclusion 
criteria will be identified by a computer-aided search 
of the Cochrane Central Register of Controlled Trials 
(CENTRAL) (The Cochrane Library), MEDLINE, 
CINAHL, Embase and PsycINFO databases from the 
period of inception to May 2019. We will use the Poly-
glot Search Translator (http:// crebp- sra. com/#/ poly-
glot) to translate the search strategy across the different 
databases. The databases will be searched using a variety 
of subject headings, free text terms and synonyms rele-
vant to the review in consultation with a librarian with 
expertise in systematic review searches. Initial terms 
will be drawn from a small set of key articles. We will 
use an iterative process to build the search strategy, run 
the search, scan the relevant retrieved articles for addi-
tional terms and then rebuild the search strategy with the 
newly identified relevant terms and related subject head-
ings. The search will consist of two rows of terms which 
will be combined with the word ‘AND’. The first row of 
search terms will be related to nudge-interventions. The 
second row of search terms will be related to the concepts 
of overuse and underuse of health services (see online 
supplementary appendix for proposed search strategy). 
We will conduct citation tracking for included studies in 
Web of Science and will perform reference checking on 
all included studies. In addition to database searching, 
we will examine the reference lists of key articles and 
relevant reviews (eg, Cochrane EPOC reviews), and hand 
search The US National Institutes of Health Clinical Trials 
Registry (http:// clinicaltrials. gov/), The Australian and 
New Zealand Clinical Trials Registry ( www. anzctr. org. au) 
and The WHO International Clinical Trials Registry Plat-
form ( www. who. int/ ictrp/). We will contact investigators 
known to be involved in previous studies that have not yet 
been published. We will also contact published authors 
in the field of nudging/behavioural insights/behavioural 
economics and ask if they are aware of ongoing and unpub-
lished trials. We will also review government department 
websites that develop and test behavioural approaches to 
public policy and service delivery (eg, UK and Australian 
‘Behaviour Insights’ team websites) for eligible trials.
Inclusion/exclusion criteria
Study design
All study types that include a control comparison will 
be included. For example, randomised trials, non-ran-
domised trials with concurrent controls, controlled 
before and after studies, controlled studies with only post-
test measures and interrupted time series studies will all 
be included.
Population
Any qualified health professional, across any specialty or 
setting, will be included. Both real clinical and scenar-
io-based studies  will be eligible.
Interventions
Only nudges that are aimed at altering the behaviour 
of health professionals will be included. Nudge-inter-
ventions lack definitional and conceptual clarity in the 
healthcare setting. Based on examination of reviews 
already completed by the Cochrane Effective Practice and 
Organisation of Care (EPOC) group, extensive reading of 
the nudge literature52 54 59 65–68 and the Behaviour Change 
Taxonomy,69 we will include the following categories of 
interventions:
Choice architecture nudges (environmental 
restructuring)
 ► Default option nudges (eg, changing the preselected 
number of medications in the order set menu).
 ► Active choice nudges.
 ► Framing and salient effect nudges (eg, require one 
additional click to order a certain test or treatment, 
test form redesign, test results report redesign, 
removal of certain tests from the main order menu, 
adding certain tests).
 ► Order effect nudges (eg, changing the order of items 
on an existing chart, form or order entry system).
Social nudges
 ► Accountable justification (eg, a requirement to justify 
a test request or treatment).
 ► Pre-commitment or publicly declared pledge/
contract (eg, a health professional pre-committing to 
a particular behaviour by publicly signing a letter or 
poster).
Studies examining the following interventions will be 
excluded:
 ► Interventions that restrict the freedom of choice (eg, 
elimination or restricting the availability of certain 
tests or treatments, mandatory use of a request form).
 ► Regulatory or policy interventions.
 ► Audit and feedback. Audit and feedback has been 
defined as 'any summary of clinical performance of 
healthcare over a specified period of time' or 'clinical 
performance feedback'.70 The feedback can include 
recommendations for clinical action and may be 
delivered in a written, electronic or verbal format.70 
This means brief feedback letters sent to clinician 
(peer-comparison or otherwise) will be excluded.
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 ► Clinical decision support systems or new order entry 
systems that feature substantial changes and require 
health professional training and competence.
 ► Financial incentives to clinicians.
 ► Mass-media interventions.
 ► Educational interventions or involving an educational 
or training component.
 ► Opinion leaders.
 ► Charge display or price transparency. While these are 
minimal interventions, these interventions have been 
covered extensively in other systematic reviews.71 72
 ► Computerised or paper-based reminders or alerts. 
Alerts are perceived as intrusive, and are therefore 
hard to avoid, and are not ‘light touch’ in nature.73 
Reminders have been covered extensively by the 
Cochrane EPOC group.74–76
Comparison
There will be no restriction on the comparator.
Outcomes
Studies with outcomes relevant to overuse or underuse 
of health services will be included. We define overuse as 
provision of an inappropriate test or treatment. We define 
underuse as failure to provide an appropriate test or treat-
ment. Therefore, to evaluate overuse and underuse, all 
studies must report some measure of appropriateness. We 
will consider measures that reference clinical guidelines, 
best evidence, a recent policy decision, the Choosing 
Wisely initiative or expert clinician consensus to deter-
mine whether the test or treatment of interest was appro-
priate or inappropriate. Measures of appropriateness 
might include
 ► Rate of inappropriate test requests or treatments 
against national or international guidelines (overuse).
 ► Rate of not requesting appropriate tests or providing 
appropriate treatments against national or interna-
tional guidelines (underuse).
 ► Rate of author-defined or hospital policy-defined 
‘inappropriate’ test requests or treatments (ie, without 
specific reference to national or international guide-
lines) (possible or grey zone overuse).
 ► Rate of not providing author-defined or hospital 
policy-defined ‘appropriate’ tests or treatments (ie, 
without specific reference to national or international 
guidelines) (possible or grey zone underuse).
Studies will be excluded if they do not include a 
measure of appropriateness based on clinical guidelines, 
best evidence, a recent policy decision, the Choosing 
Wisely initiative or local clinical consensus.
All clinical tests and treatment behaviours will be 
eligible at all study time points.
Primary outcomes
Health professionals' overuse or underuse of tests or treatments
Dichotomous outcomes relating  to health professionals’ 
use of any test (eg, proportion of patients/requests for 
imaging, screening, laboratory tests that were appropriate/
inappropriate) or treatment (eg, proportion of patients/
treatments provided (eg, medications, non-pharmacolog-
ical therapies) that were appropriate/inappropriate) will 
be included. Where possible for dichotomous outcomes, 
we will report a single effect size for the study’s stated 
primary outcome in each study. Below are examples of 
measuring our outcomes of interest:




Number of people who consulted with Clinical
Presentation A and received an inappropriate
test or treatment for Clinical Presentation A




Number of people who consulted with Clinical
Presentation A and failed to receive an appropriate
test or treatment for Clinical Presentation A
Number of people who consulted with Clinical Presentation A  




Number of requests for Test A or Treatment
A that were inappropriate for people who
consulted with Clinical Presentation A
Number of requests for Test A or Treatment A for people




Number of requests for Test A or Treatment
A that were appropriate for people who
consulted with Clinical Presentation A
Number of requests for Test A or Treatment A for people
who consulted with Clinical Presentation A in total   
secondary outcomes
Health professionals' overuse or underuse of tests or treatments
Continuous outcomes relating  to health professionals’ 
use of testing and treatment (eg, duration of interven-
tion, mean number of intervention sessions/provision) 
will be includedFor continuous outcomes, we will report 
the results in natural units, as reported by the study 
authors, and extract data on the absolute or relative 
change in testing or treatment practices from baseline or 
across groups.
Patient outcomes
1. Dichotomous clinical outcomes: patient-important 
endpoints (eg, death, recurrence of illness).
2. Continuous clinical outcomes: various markers of dis-
ease (eg, disability, pain, quality of life, patient satis-
faction, length of stay in hospital). Given our broad 
scope (all health conditions), it is not possible to pre-
specify eligible patient outcomes. We will focus on the 
core patient-relevant outcomes as specified in that 
disease area. For example, in the LBP field, physical 
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functioning and health-related quality of life are con-
sidered core outcomes to measure in clinical trials.
Costs
Any measure of cost(s) of test orders, cost(s) of tests 
performed, cost(s) per diagnosis, cost(s) of treatment or 
overall healthcare costs will be included.
Adverse effects
Some of the interventions evaluated may have unin-
tended impacts on patient care or health professional 
workflows. For example, if nudges are intended to reduce 
the overuse of a certain test, they may lead to the underuse 
of this test for appropriate populations, or the reductions 
in use of one test may inadvertently increase the use of 
another inappropriate test or treatment.
We will examine the adverse (undesirable) effects of 
interventions recommended by the Cochrane EPOC 
group.77 These will include adverse effects on
1. Test and treatment delivery or utilisation.
2. Health or health behaviours.
3. Quality of care.
4. Resource use.
Where no adverse effects are reported, we will make a 
distinction between studies where adverse effects were 
investigated, studies where it is unclear whether adverse 
effects were investigated and studies where it is clear that 
adverse effects were not investigated.
study selection
One review author (MOK) will download search results to 
the reference manager software Endnote. Deduplication 
of results will be completed in the Centre for Research 
in Evidence Based Practice Systematic Review Acceler-
ator deduplication algorithm. This algorithm has greater 
sensitivity and specificity than Endnote for the dedu-
plication process.78 Data will be managed in Endnote 
thereafter. Two review authors (MOK and GEF) will inde-
pendently assess the eligibility of studies by screening 
titles and abstracts in Endnote for potential inclusion 
according to the predefined selection criteria. Studies 
judged to be potentially relevant will be retrieved in full 
text for further analysis. Any disagreements in judgement 
will be resolved by discussion to reach a consensus, or if 
this is not possible, with a third review author (ACT) until 
a consensus is reached. If further information about the 
study is required in order to make a decision about its 
eligibility, an attempt will be made to contact the study 
corresponding author(s).
data extraction
Two review authors (MOK and ACT) will independently 
extract data for each of the included studies using a modi-
fied EPOC data collection checklist. The data extraction 
spreadsheet will be pilot tested on two included studies to 
minimise misinterpretation. We will extract information 
about study design, characteristics of population (country, 
setting, specialty, number of health professionals, 
number of patients), details of the interventions using 
TIDieR items79, details of the outcomes (target behaviour, 
measure of the target behaviour, baseline performance of 
the healthcare professional, patient outcome) and study 
results. If not enough information is provided in the trial 
report to extract data about intervention effects, we will 
contact authors to attempt to obtain the required infor-
mation. We will calculate data from graphs and figures 
using https://www. digitizeit. de/ in cases where this infor-
mation is not presented in tables or text. If any informa-
tion regarding standard deviations (SDs) is missing, we 
will calculate them from the extracted confidence inter-
vals (if available) of the same study.
risk of bias assessment
Two authors (MOK and GEF) will assess the risk of bias 
of all eligible studies using the criteria described in the 
Cochrane EPOC Group Resources for review authors.80 
Nine standard criteria are suggested for all randomised 
trials, non-randomised trials and controlled before-after 
studies. Seven standard criteria are used for all inter-
rupted time series studies. Any disagreements in judge-
ment will be resolved by discussion to reach a consensus, 
or if this is not possible, with another reviewer (ACT) 
until a consensus is reached.
Where possible, we will assess the overall certainty of the 
evidence using The Grades of Recommendation, Assess-
ment, Development and Evaluation (GRADE) approach 
as recommended in the Cochrane Handbook for Systematic 
Reviews of Interventions.81
data synthesis
We will follow the Cochrane EPOC guidelines for 
reporting the effects of interventions.82
We expect that the included studies will vary according 
to study design, health professionals included, setting, 
types of nudge and target behaviours. Therefore, we 
expect to report our results in a structured synthesis 
format, as recommended by the Cochrane EPOC group.
We will separately analyse and report outcome data 
from different types of study designs. Depending on the 
studies found, we will also separately analyse and report 
the outcome data for the differentcategories (choice 
architecture and social nudges) and/or subcategories of 
nudges (eg, defaults, pre-commitment). Furthermore, 
depending on the studies found, we will separately analyse 
and report outcome data on the interventions that target 
testing or treatment behaviours.
In our structured synthesis, we will try to examine if there 
are any patterns or variations across different factors and 
outcomes achieved. Subgroups of interest may include 
the type of nudge, type of healthcare professional, type 
of setting, type of target behaviour and whether the study 
examined a real clinical or hypothetical/simulated situa-
tion (eg, a vignette study).
dealing with missing data
We will contact authors of included papers if important 
data are not available.
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Patient or public involvement
Patients and members of the public will not be involved 
in the design of this study.
Ethics and dissemination
Formal ethical approval is not required for this study. 
The results will be disseminated through a peer-reviewed 
publication and conference presentations.
COnClusIOn
This systematic review will provide evidence in support 
or against the hypothesis that nudge-interventions aimed 
at health professionals can address health service overuse 
and underuse. The results will have important implica-
tions for the implementation of health system inter-
ventions to improve professional practice and patient 
outcomes.
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